|
Mr. Glickman joins Oscient from Bayer Healthcare’s Diabetes Care Division a $500 million franchise with over 500 employees where he served as Vice President of Sales. Prior to the acquisition of Kos Pharmaceuticals by Abbott Mr. Glickman helped build the company’s commercial organization as Vice President of Sales. Previously as Director of Marketing Mr. Glickman was responsible for the launch of ADVICOR the second commercial product for Kos. Prior to Kos he was at Bristol-Myers Squibb as a cardiovascular product manager and senior product manager for PLAVIX and VANLEV where during his tenure he contributed to a $400 million increase in PLAVIX revenue. Mr. Glickman also was employed by Baxter Healthcare as a sales specialist regional sales manager and then as General Manager of Sales for a $100 million medical and surgical supply portfolio. Mr. Glickman received his M.B.A. from New York University and a B.A. in Political Science from the State University of New York. | 